Driving pharmaceutical innovation through advanced formulation technologies and customized pellet development.
Utilizing state-of-the-art facilities to deliver high-capacity production of custom immediate and modified-release pellets.
Maximizing production efficiency through advanced facilities while maintaining deep custom-formulation flexibility.
Meeting rigorous international regulatory requirements to ensure absolute quality, safety, and trust.
Incorporated in 2006, Scoat Pharma is a trusted symbol in developing, manufacturing, and exporting premium pharmaceutical pellets, co-promoted by the prestigious Suraksha Group.
We specialize in customized manufacturing of Immediate Release, Modified Release, Enteric Coated Pellets, and Retard Micro Granules inside our state-of-the-art facility.
2025 Milestone: Relocated to a highly advanced facility maximizing production output and expanding our reach across global markets.
Customers
Countries
People
API's
Manufacturing Sites